Stocktoria

Incannex Healthcare Inc. IXHL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-03-18

Incannex Healthcare Inc. statistics & valuation

Market cap$40.9M
P / B0.6×
Return on equity-28.6%
Return on capital-32.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20232023202420252026
Operating margin (%)
-250341.70% -27661.60% 20232023202420252026
Return on equity (%)
-234.40% -164.60% -350.20% -28.60% 20232023202420252026
Shares outstanding
1.59B 15.9M 17.6M 6.5M 12.5M 20232023202420252026
Net debt ($)
20232023202420252026
Share buybacks ($)
20232023202420252026
Return on assets (%)
-205.20% -108.30% -229.30% -26.40% 20232023202420252026
Free cash flow margin (%)
-134350.00% -14559.30% 20232023202420252026
Debt / equity (×)
20232023202420252026
EPS ($)
-$3.32 -$1.15 -$40.82 -$1.66 20232023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2023
Operating margin—-27661.6%-250341.7%——
Net margin—-54517.4%-153825.0%——
FCF margin—-14559.3%-134350.0%——
Return on assets-26.4%-229.3%-108.3%—-205.2%
Return on equity-28.6%-350.2%-164.6%—-234.4%
Current ratio48.812.862.886.709.02

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.